Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05176548 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Patients with Suspected Amyloidosis in Heart Failure

Study acronym: Regamic
StatusActive, Not Recruiting
PhaseNot specified
Started2022-01-15
View on ClinicalTrials.gov ↗

Amendment history

2024-09-30
Recruiting→Active, Not Recruiting Study Identification, Study Status, Sponsor/Collaborators, Oversight, Contacts/Locations, IPDSharing v2
Trial statusRecruiting→Active, Not Recruiting
Primary completion dateestimated 2023-12-31→confirmed 2024-03-31
Study sitesdetails revised at 1 of 1 site
Collaborators+6 characters
Pfizer
Study titlerevised
Registry of Patients Withwith Suspected Amyloidosis in Heart Failure
2023-02-14
Not Yet Recruiting→Recruiting Study Status, Study Description, Eligibility, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2022-01-01→confirmed 2022-01-15
Study sites0→1
Eligibility criteria+20 characters
INCLUSION CRITERIA: Age ≥ 18 years. Both genders. Heart Failure (2021 European S [...] ricular conduction disease Possible family history of ATTRv ExclusionEXCLUSION CriteriaCRITERIA: Refusal to participate in the registry
Study description+15 characters
[...] atients in the group with CA, and a follow-up of two years. WeThe investigators estimate a sample size of at least 150 patients in the Grou [...]
2021-12-14
Original filing
Observational multicenter registry of cohorts with follow-up. Patients with heart failure, age ≥ 18 years, with clinical suspicion of cardiac amyloidosis and any LVEF value, treated in the field of Internal Medicine. Initially, a duration of two years was established to recruit at least 150 patients in the group with AC, and a follow-up of two years. Upon completion of the two years of follow-up, the continuity or completion of the registry will be assessed.
Trial Details
NCT Number NCT05176548
Lead Sponsor Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Collaborators: Pfizer
Conditions Heart Failure
Enrollment 450 participants
Start Date 2022-01-15
Primary Completion 2024-03-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-01